CN1182130C - 疯草中苦马豆素的提纯工艺 - Google Patents
疯草中苦马豆素的提纯工艺 Download PDFInfo
- Publication number
- CN1182130C CN1182130C CNB021145903A CN02114590A CN1182130C CN 1182130 C CN1182130 C CN 1182130C CN B021145903 A CNB021145903 A CN B021145903A CN 02114590 A CN02114590 A CN 02114590A CN 1182130 C CN1182130 C CN 1182130C
- Authority
- CN
- China
- Prior art keywords
- trihydroxyoctahydroindolizidine
- whin
- crude product
- swainsonine
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 244000025254 Cannabis sativa Species 0.000 title claims description 5
- FXUAIOOAOAVCGD-UHFFFAOYSA-N swainsonine Natural products C1CCC(O)C2C(O)C(O)CN21 FXUAIOOAOAVCGD-UHFFFAOYSA-N 0.000 title abstract description 7
- FXUAIOOAOAVCGD-FKSUSPILSA-N swainsonine Chemical compound C1CC[C@H](O)[C@H]2[C@H](O)[C@H](O)CN21 FXUAIOOAOAVCGD-FKSUSPILSA-N 0.000 title abstract description 7
- 229960005566 swainsonine Drugs 0.000 title abstract description 7
- 239000012043 crude product Substances 0.000 claims abstract description 40
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 37
- 241001061264 Astragalus Species 0.000 claims abstract description 35
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 claims abstract description 33
- 240000003864 Ulex europaeus Species 0.000 claims abstract description 27
- 235000010730 Ulex europaeus Nutrition 0.000 claims abstract description 27
- 229930013930 alkaloid Natural products 0.000 claims abstract description 20
- 150000003797 alkaloid derivatives Chemical class 0.000 claims abstract description 20
- 239000000047 product Substances 0.000 claims abstract description 15
- 238000000260 fractional sublimation Methods 0.000 claims abstract description 11
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 90
- 239000000284 extract Substances 0.000 claims description 66
- 239000007788 liquid Substances 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 11
- DVQGSNPWOLEDRV-UHFFFAOYSA-N 4-(2,2-dimethyl-7,8-dihydro-6h-pyrano[3,2-g]chromen-7-yl)-2,3-dimethoxyphenol Chemical compound COC1=C(O)C=CC(C2CC3=CC=4C=CC(C)(C)OC=4C=C3OC2)=C1OC DVQGSNPWOLEDRV-UHFFFAOYSA-N 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241000220100 Oxytropis ochrocephala Species 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 6
- 239000003729 cation exchange resin Substances 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 238000011084 recovery Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 235000012054 meals Nutrition 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 abstract description 35
- 241000196324 Embryophyta Species 0.000 abstract description 14
- 238000009826 distribution Methods 0.000 abstract description 5
- 231100000614 poison Toxicity 0.000 abstract description 4
- 230000007096 poisonous effect Effects 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000005341 cation exchange Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 229940107666 astragalus root Drugs 0.000 abstract 3
- 241000220485 Fabaceae Species 0.000 abstract 1
- 241000827798 Hemerocallis citrina Species 0.000 abstract 1
- 229960001701 chloroform Drugs 0.000 abstract 1
- 230000001473 noxious effect Effects 0.000 abstract 1
- 238000004611 spectroscopical analysis Methods 0.000 description 9
- 241000147945 Oxytropis kansuensis Species 0.000 description 7
- 238000004817 gas chromatography Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000003513 alkali Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 238000002329 infrared spectrum Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000001819 mass spectrum Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 229960001866 silicon dioxide Drugs 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- ONBIUAZBGHXJDM-UHFFFAOYSA-J bismuth;potassium;tetraiodide Chemical compound [K+].[I-].[I-].[I-].[I-].[Bi+3] ONBIUAZBGHXJDM-UHFFFAOYSA-J 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000000859 sublimation Methods 0.000 description 4
- 230000008022 sublimation Effects 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 241000293302 Astragalus mollissimus Species 0.000 description 2
- 241000147951 Astragalus strictus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000293006 Oxytropis sericea Species 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- WXELLRXNGRTSJY-VARJHODCSA-N (1s,2r,8r,8ar)-4-oxido-1,2,3,5,6,7,8,8a-octahydroindolizin-4-ium-1,2,8-triol Chemical compound C1CC[C@@H](O)[C@@H]2[C@H](O)[C@H](O)C[N+]21[O-] WXELLRXNGRTSJY-VARJHODCSA-N 0.000 description 1
- NLMQHXUGJIAKTH-UHFFFAOYSA-N 4-hydroxyindole Chemical class OC1=CC=CC2=C1C=CN2 NLMQHXUGJIAKTH-UHFFFAOYSA-N 0.000 description 1
- XCOBLONWWXQEBS-KPKJPENVSA-N N,O-bis(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000217952 Sphaerophysa salsula Species 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229930002371 pyridine alkaloid Natural products 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
指标体系 | 技术性能 |
外观 | 白色细针状结晶 |
熔点 | 144~145℃ |
薄层层析 | 在硅胶板上Rf值0.44处有一紫红色斑点 |
红外光谱(IR) | 有典型的Bohlman band吸收 |
质谱(MS) | 分子离子峰为173 |
气相色谱(GC) | TMS衍生物保留时间13.77min |
保质期 | 无菌抽真空分装,密封保存于-4℃冰箱,保质期3年 |
生化特性 | a-甘露糖甙酶高效、专一抑制剂 |
分子量 | 173 |
酸离解常数 | Pka 7.4 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021145903A CN1182130C (zh) | 2002-05-24 | 2002-05-24 | 疯草中苦马豆素的提纯工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021145903A CN1182130C (zh) | 2002-05-24 | 2002-05-24 | 疯草中苦马豆素的提纯工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1396161A CN1396161A (zh) | 2003-02-12 |
CN1182130C true CN1182130C (zh) | 2004-12-29 |
Family
ID=4743175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021145903A Expired - Fee Related CN1182130C (zh) | 2002-05-24 | 2002-05-24 | 疯草中苦马豆素的提纯工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1182130C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331468C (zh) * | 2003-05-21 | 2007-08-15 | 杨凌大农生物技术有限公司 | 一种用于治疗癌症的植物提取物 |
CN101270118B (zh) * | 2007-03-22 | 2012-05-23 | 贺武利 | 连续柱层析法提纯苦马豆素的工艺 |
CN102432609A (zh) * | 2011-12-15 | 2012-05-02 | 西藏自治区农牧科学院 | 一种茎直黄芪中苦马豆素的微波辅助提取工艺 |
CN103319481B (zh) * | 2013-07-05 | 2014-12-17 | 西藏自治区农牧科学院 | 茎直黄芪中苦马豆素的提取工艺 |
-
2002
- 2002-05-24 CN CNB021145903A patent/CN1182130C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1396161A (zh) | 2003-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1919222A (zh) | 一种三七总皂苷的制备方法 | |
CN102631414B (zh) | 地不容总生物碱提取纯化工艺 | |
JP4757911B2 (ja) | マグノリアの皮質又はマグノリアの根からのマグノロールの大量分離方法 | |
CN1308277C (zh) | 从中药决明子中提取蒽醌类化合物的方法 | |
CN1112366C (zh) | 人参总皂苷的提取方法 | |
CN104163755A (zh) | 一种从厚朴叶中制备厚朴酚及和厚朴酚的方法 | |
CN110496179B (zh) | 一种提取槟榔果实中抗氧化物质的方法及应用 | |
CN1182130C (zh) | 疯草中苦马豆素的提纯工艺 | |
EP2650301B1 (en) | Method for preparing albiflorin and paeoniflorin | |
CN101759757A (zh) | 一种甘草酸的制备方法 | |
CN105669797B (zh) | 一种从牛蒡子中分离牛蒡子油、牛蒡苷、牛蒡苷元、牛蒡酚e和牛蒡酚h的方法 | |
CN102488819A (zh) | 萱草花提取物的制备方法 | |
CN101078713A (zh) | 一种加入内标物的绞股蓝药材指纹图谱质量控制方法 | |
CN1332969C (zh) | 黄酮苷类化合物及其制备方法 | |
CN102060822A (zh) | 一种从紫花地丁中提取七叶内酯的方法 | |
CN103554209A (zh) | 从三七中制备人参皂苷Rg1的方法 | |
CN1900106A (zh) | 一种中药提取物的制备方法和质量控制方法 | |
CN101050214A (zh) | 一种从疯草中提取苦马豆素的新方法 | |
CN1839936A (zh) | 具抗血栓活性的丹参提取物和制备方法 | |
CN1247564C (zh) | 一种富集藁本内酯的工艺及其制剂 | |
CN102836280A (zh) | 枸杞叶总黄酮提取物及其制备方法 | |
CN106831936A (zh) | 采用中、高压制备液相法制备丹参酮iia和二氢丹参酮i的方法 | |
CN1546483A (zh) | 沙棘黄酮配基的高纯度提取方法 | |
CN1304405C (zh) | 丁香甙的提取方法 | |
CN101270118A (zh) | 连续柱层析法提纯苦马豆素的工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GE PENGBIN Free format text: FORMER OWNER: YANGLING DANONG BIOLOGY TECHNOLOGY CO., LTD. Effective date: 20071026 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20071026 Address after: 712100 room 307, building, Yangling demonstration zone, Shaanxi Province Patentee after: Ge Pengbin Address before: 712100 room 307, Yangling pioneering building, Shaanxi Province Patentee before: Danong Biotechnology Co., Ltd., Yangling |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041229 |